| http://www.w3.org/ns/prov#value | - In particular the invention relates to the prevention and/or treatment of pulmonary arterial hypertension by administering a therapeutically effective amount of a compound that is both a 5-HT2 A and 5-HT 2 B receptor antagonist to an animal including mammals in general and humans in particular, for the treatment or prevention and/or treatment of pulmonary arterial hypertension (PAH).
|
